MAXGLA+
MaxGLA+ is a sterile liquid glycosylation modulator from Shanghai Mediumbank Biotechnology Co., Ltd., designed to enhance galactose occupancy on oligosaccharides. It effectively increases G1F and G2F glycoforms while reducing GOF forms, improving N-linked glycosylation profiles in various CHO cell lines. This animal-derived component-free solution is ideal for batch and fed-batch cultures, supporting efficient antibody galactosylation.
Pharmazeutische Inhaltsstoffe